Synergy Pharmaceuticals Announces Positive Results For Second Phase 3 Trial
July 30, 2015 at 20:07 PM EDT
Synergy Pharmaceuticals announces positive results for second phase 3 trial in patients with chronic idiopathic constipation. After a premarket jump, stock settled up 4.75% on the day.
